CardioKinetix heads to Malaysia to treat the 1st Asian patients with the Parachute ventricular partitioning device.
Four patients in Kuala Lumpur, Malaysia were successfully treated with CardioKinetix’s catheter-based Parachute ventricular partitioning device, the Menlo Park, Calif.-based firm announced late last month.
The Parachute device is a minimally invasive catheter-based treatment which separates damaged heart muscle from healthy tissue to decrease the overall volume of the left ventricle and restore its geometry and function.